Author:
Smith Dallas J.,Lambrou Anastasia,Patel Pragna
Publisher
Centers for Disease Control MMWR Office
Subject
Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology
Reference23 articles.
1. National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines. Washington, DC: US Department of Health and Human Services, National Institutes of Health. https://www.covid19treatmentguidelines.nih.gov/Accessed December 5, 2023.
2. Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19.;Hammond;N Engl J Med,2022
3. Early remdesivir to prevent progression to severe COVID-19 in outpatients.;Gottlieb;N Engl J Med,2022
4. Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients.;Jayk Bernal;N Engl J Med,2022
5. Anti-SARS-CoV-2 pharmacotherapies among nonhospitalized U.S. veterans, January 2022 to January 2023.;Yan;JAMA Netw Open,2023
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献